Home Stock

Stock Research: Eckert & Ziegler

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Eckert & Ziegler

XTRA:EUZ DE0005659700
100
  • Value
    96
  • Growth
    87
  • Safety
    Safety
    57
  • Combined
    100
  • Sentiment
    53
  • 360° View
    360° View
    100
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Eckert & Ziegler SE provides isotope technology for medical, scientific, and industrial use, focusing on cancer therapy, industrial radiometry, and nuclear-medical imaging. The company operates in radiation therapy, isotope products, and radiopharma. It operates in Germany. In the last fiscal year, the company had a market cap of $1651 million, profits of $148 million, and revenue of $306 million with 1085 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 100 (better than 100% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Eckert & Ziegler are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Eckert & Ziegler. The consolidated Value Rank has an attractive rank of 57, which means that the share price of Eckert & Ziegler is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 57% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 96. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 53. ...read more

more
Country Germany
Industry Health Care Equipment
Size Small
Website ezag.com
Index
CDAX
SDAX
TecDAX
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 8 24 9
Growth
87 100 49 55
Safety
Safety
96 90 94 84
Sentiment
53 100 95 100
360° View
360° View
100 96 90 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
77 95 97 1
Opinions Change
10 86 50 96
Pro Holdings
n/a 85 74 81
Market Pulse
54 69 82 88
Sentiment
53 100 95 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 8 24 9
Growth
87 100 49 55
Safety Safety
96 90 94 84
Combined
100 92 66 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
59 15 25 14
Price vs. Earnings (P/E)
41 34 42 17
Price vs. Book (P/B)
50 13 36 10
Dividend Yield
42 19 34 35
Value
57 8 24 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
59 77 76 38
Profit Growth
84 94 20 34
Capital Growth
61 96 59 29
Stock Returns
91 96 33 99
Growth
87 100 49 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
82 73 84 84
Refinancing
71 70 65 43
Liquidity
78 63 71 72
Safety Safety
96 90 94 84

Similar Stocks

Discover high‑ranked alternatives to Eckert & Ziegler and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Hornbach Holding

XTRA:HBH
Country: Germany
Industry: Home Improvement Retail
Size: Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.